Organogenesis Holdings (ORGO) Return on Capital Employed Growth (3y) (2020 - 2026)
Organogenesis Holdings (ORGO) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 1,902.00 |
| 10 | Organogenesis Holdings | 330.36 Mn | 238.26 Mn | 11.46 Mn | -443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -443.00 |
| Dec 31, 2025 | 395.00 |
| Sep 30, 2025 | -1,119.00 |
| Jun 30, 2025 | -1,909.00 |
| Mar 31, 2025 | -2,225.00 |
| Dec 31, 2024 | -2,261.00 |
| Sep 30, 2024 | -2,974.00 |
| Jun 30, 2024 | -3,488.00 |
| Mar 31, 2024 | -2,037.00 |
| Dec 31, 2023 | -1,023.00 |
| Sep 30, 2023 | 400.00 |
| Jun 30, 2023 | 2,329.00 |
| Mar 31, 2023 | 2,551.00 |
| Dec 31, 2022 | 2,757.00 |
| Sep 30, 2022 | 3,715.00 |
| Jun 30, 2022 | 4,125.00 |
| Mar 31, 2022 | 5,357.00 |
| Dec 31, 2021 | 5,032.00 |
| Sep 30, 2021 | 4,235.00 |
| Jun 30, 2021 | 4,550.00 |